Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-cohort Study on Efficacy and Safety of IBI363 for Advanced Solid Tumors

NCT06081907 is registered in ClinicalTrials.gov with Hunan Province Tumor Hospital as lead sponsor.

NCT NCT06081907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06081907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-cohort Study on Efficacy and Safety of IBI363 for Advanced Solid Tumors
Lead sponsor
Hunan Province Tumor Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
December 25, 2023
Completion date
September 1, 2028
Enrollment
430 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor